Implicity®, a leading provider of remote patient monitoring and cardiac data management solutions, announced that it has been selected to compete in the Health Tech Challengers (HTC) Super Finals, taking place live at HLTH 2022.
The global competition identifies top companies driving digital health innovation. Implicity won the Cardiovascular Track and is one of only eight startups invited to present in person at the live event in Las Vegas on November 15 at 2:00 p.m. in the Venetian Ballroom D, Lvl 2, where the final winner will be announced.
“We are honored to be part of such an impressive group of finalists. This recognition validates the positive impact of our AI-powered platform on cardiologists and healthcare professionals caring for patients with CIEDs. These remote cardiac monitoring solutions are producing more and more data every year. The only way for clinicians to process all of this is with tools based on artificial intelligence. We are proud to bring to market a solution that can improve the everyday lives of physicians and allow them to spend more time with their patients,” said Dr. Arnaud Rosier, Electrophysiologist, CEO and Co-Founder of Implicity.